Olumiant
Olumiant ingredients
| Active ingredient | Strength |
|---|---|
| Baricitinib | 2 mg/1, 1 mg/1, 4 mg/1 |
What Olumiant is used for
The FDA lists the approved uses on the official label (below). In the EU, baricitinib is approved as Olumiant for:
Rheumatoid arthritis Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (DMARDs). Olumiant may be used as monotherapy or in combination with methotrexate. Atopic Dermatitis Olumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. Alopecia areata Baricitinib is indicated for the treatment of severe alopecia areata in adult and adolescent patients 12 years of age and older. Juvenile idiopathic arthritis Baricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventio…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Olumiant
- Generic name
- Baricitinib
- Made by
- Eli Lilly and Company
- Forms
- Tablet, Film Coated
- Given
- Oral
- Drug class
- Janus Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA207924
- On the US market since
- 2018
Official information
- MedlinePlus drug information (search for Baricitinib)
In India
- Baricitinib: 9 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Olumiant?
Olumiant (Baricitinib) is a cancer medicine made by Eli Lilly and Company, approved by the US FDA.
What are the ingredients of Olumiant?
Olumiant contains Baricitinib (2 mg/1, 1 mg/1, 4 mg/1).
Is Olumiant approved in Europe?
The same active substance is approved in the EU as Olumiant.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA